BioCorRx Inc. (OTCMKTS:BICX – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.98 and traded as high as $1.47. BioCorRx shares last traded at $1.47, with a volume of 200 shares traded.
BioCorRx Stock Down 2.0 %
The stock has a market cap of $13.05 million, a PE ratio of -3.27 and a beta of 0.59. The firm has a 50-day simple moving average of $0.98 and a 200-day simple moving average of $1.10.
BioCorRx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
See Also
- Five stocks we like better than BioCorRx
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Silicon Motion Proves That AI in Motion Stays in Motion
- How to Read Stock Charts for Beginners
- Undervalued UnitedHealth Group Won’t Be For Long
- Comparing and Trading High PE Ratio Stocks
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
